Helixgate https://validator.w3.org/feed/docs/rss2.html Home New U.S. recommendation on hepatitis B vaccine will have dire consequences, studies project STAT+: Erasca touts strong, though preliminary, results in trial of pancreatic and lung cancer therapy Erasca reports RAS cancer drug data after legal threat from Revolution Sun Pharma Aims for Top 3 in Women’s Health with $11.75B Organon Purchase Dems say RFK Jr. has a pattern of failing to answer their questions Revolution Medicines threatens to sue Erasca over patent, efficacy claims Trump administration warns against using federal dollars on fentanyl test strips Anticancer Strategy Targets Defense Mechanism in Senescent Cells Oruka surges as long-acting psoriasis drug shows early promise The structural data bottleneck in AI antibody discovery Q&A: Intellia CEO talks first Phase 3 CRISPR readout and what’s next Monoclonal Antibodies: Unlocking Cost and Efficiency Gains in Downstream Processing Compass shares crash as ‘confounding’ survival data raise approvability questions for bispecific STAT+: An insider reveals the real goals of prior authorization Sun Pharma beams up Organon in $11.75B acquisition Oruka posts Phase 2 win in psoriasis, hoping to compete with Skyrizi Genetic Medicine Delivery Enhanced by Producer Cell Modifications STAT+: Astellas retries XLMTM gene therapy after deaths Lilly lands third oncology deal in 3 weeks, inking up to $2.3B for Ajax Intellia heads to FDA after notching first late-stage win for in vivo gene editor Lilly announces a new cancer deal, paying Ajax up to $2.3B for JAK inhibitor UCSF, Par Health hit with FDA warning letters for environmental monitoring issues Seaport, Hemab chart courses for $180M IPOs to fund depression, clotting candidates Compass Therapeutics unveils key secondary endpoint results from pivotal biliary tract cancer trial Rejuvenate crowdfunds development of gene therapy for aging, chronic diseases StockWatch: Trump Order Lifts Psychedelic Drug Shares STAT+: Intellia says CRISPR-based treatment for rare disease reduced swelling attacks in pivotal trial Veradermics wins at growing hair with oral Rogaine in first key test as a public company Nancy Cox, a CDC veteran and a stalwart in global flu research, dies at 77 J&J puts blockbuster blood thinner Xarelto on TrumpRx STAT+: Zap in a cap: How one neurotech startup is using a hat to treat depression Abdominal Contractions May Drive Brain Fluid Flow, Aiding in Neural Waste Clearance Opinion: The podcast telling the stories behind Ambien, Ozempic, EpiPens, and other game-changing drugs What happened to Covid? Sun Pharma to buy Organon for $11.75B in major portfolio expansion Turn health data into impact: Browns University’s online master in biostatistics & health data science Gene therapy leaders aim to help more Baby KJs with novel regulatory models Investment in UK biotechs shows early signs of recovery, report says STAT+: Doctor, wife of acting U.S. attorney general appointed to NIH advisory council Sanofi’s immunology reckoning; Lilly acquires in vivo CAR-T biotech; RevMed’s ‘Herceptin moment’; and more Thermo Fisher sees higher Q1 earnings amid strong biopharma demand Engineered conductive pili enable high-efficiency photosynthetic electron extraction in biophotovoltaics Improving metagenome binning by integrating intrinsic features and taxonomy AI Learns to Predict Breast Cancer Risk from How Single Cells Respond to Pressure Single-Cell Atlas of the Prenatal Brain Reveals How Down Syndrome Reshapes Development STAT+: FDA to speed up review of three psychedelics as mental health treatments STAT+: A biotech VC on what Eli Lilly saw in a struggling cancer startup for $3.2B FDA unveils three psychedelic-focused commissioner vouchers STAT+: Utah medical board calls for immediate suspension of state’s AI doctor experiment